Zhi-yuan Xiao
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner.
Journal: Cell death & disease
Published: April 04, 2023
UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.
Journal: Cancer cell international
Published: November 14, 2018
Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 23, 2018
miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1.
Journal: Cancer cell international
Published: July 31, 2017
Downregulation of SAFB Sustains the NF-κB Pathway by Targeting TAK1 during the Progression of Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 22, 2017
MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
Journal: Oncotarget
Published: July 20, 2016
miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
Journal: Oncotarget
Published: May 13, 2016
TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.
Journal: Oncotarget
Published: August 05, 2015
The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
Journal: Cancer letters
Published: November 04, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026